Pfizer has now announced that ... and 100 times The People’s Vaccine Alliance’s estimated cost of manufacture of each vial. This estimation was drawn from an analysis of data from consumer ...

A chemical engineering professor at the University of Cincinnati is developing new ways to deliver treatments for infectious ...

Pfizer hopes a unique life-extension benefit for its Talzenna can serve to further expand the drug’s already ...

Already competing to bring the first vaccine against respiratory syncytial virus (RSV) to market, Pfizer and GSK are also fighting a patent infringement battle in the courts. Earlier this month ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

Follow the latest COVID-19 Vaccine news stories and headlines. Get breaking news alerts when you download the ABC News App and subscribe to COVID-19 Vaccine notifications.

MDV: Multidose vial; NA: Not available ... influenza vaccination campaign estimated that the total time to get a vaccine ready to be administered per patient was 87 s for MDVs and 49.71 s for ...

Diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B (recombinant) and inactivated poliovirus vaccine combined ... glargine (rDNA origin) vial or cartridge Lantus vial ...

Copyright 2025 The Associated Press. All Rights Reserved. Measles and tetanus vaccine vials are ready to be administered at the Dallas County Health & Human Services ...

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has reported a Standalone Total ...

Pre-market: 4:24:23 am GMT-5 ...